Cognitive-Behavioral and Pharmacologic (LDX) Treatment of Binge-Eating Disorder and Obesity: Medication Change for Non-Responders
Conditions
- Binge-Eating Disorder
- Obesity
Interventions
- DRUG: Naltrexone and Bupropion
- OTHER: Placebo
Sponsor
Yale University
Collaborators